Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in 2 Fractions

NCT07391982 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT07391982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07391982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in 2 Fractions
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
November 17, 2025
Completion date
December 31, 2028
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (adenocarcinoma)